U.S. federal trademark · Serial No. 88625032 · Reg. No. 6111599
Medical dosimetry services in the field of radiopharmaceutical therapy for treating cancer, hyperthyroidism, or other metabolic or physiological conditions or diseases; medical dosimetry services for diagnostic radiopharmaceuticals for diagnosis or prognosis of metabolic, functional, or physiological conditions or diseases such as neoplasia or neurological, skeletal, respiratory, digestive, cardiovascular, endocrine, reproductive disorders
Software as a service (SAAS) services featuring software tools for image analysis, risk analysis, quantitative reconstruction, dosimetry, and prediction of organ toxicity and therapeutic efficacy in the field of radiopharmaceutical therapy for use by medical and research laboratories; provide consulting services to developers of radiopharmaceuticals related to dosimetry, risk analysis, quantitative reconstruction and dosimetry
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.